bioAffinity Technologies (BIAF) Return on Assets (2022 - 2025)
Historic Return on Assets for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 1.81%.
- bioAffinity Technologies' Return on Assets fell 5300.0% to 1.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.81%, marking a year-over-year decrease of 5300.0%. This contributed to the annual value of 1.23% for FY2024, which is 4500.0% down from last year.
- Per bioAffinity Technologies' latest filing, its Return on Assets stood at 1.81% for Q3 2025, which was down 5300.0% from 2.27% recorded in Q2 2025.
- bioAffinity Technologies' Return on Assets' 5-year high stood at 0.62% during Q4 2022, with a 5-year trough of 2.27% in Q2 2025.
- In the last 4 years, bioAffinity Technologies' Return on Assets had a median value of 1.11% in 2024 and averaged 1.21%.
- Per our database at Business Quant, bioAffinity Technologies' Return on Assets crashed by -1700bps in 2024 and then plummeted by -10800bps in 2025.
- bioAffinity Technologies' Return on Assets (Quarter) stood at 0.62% in 2022, then plummeted by -39bps to 0.86% in 2023, then tumbled by -60bps to 1.38% in 2024, then tumbled by -31bps to 1.81% in 2025.
- Its Return on Assets stands at 1.81% for Q3 2025, versus 2.27% for Q2 2025 and 1.61% for Q1 2025.